Building a Better Drug: Strategies to Enhance Patient Drug Regimen Adherence | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Building a Better Drug: Strategies to Enhance Patient Drug Regimen Adherence

Rita Peters (Editorial Director, Pharmaceutical Technology)

David Lyon, Ph.D. (Director, Research, Lonza Pharma and Biotech)

Ronak Savla (Pharm.D., Ph.D. Scientific Affairs Manager , Catalent Pharma Solutions)

Location: E353b

Date: Tuesday, April 30

Time: 9:45am - 10:30am

Track: Drug Development

Vault Recording: TBD

Therapies will not produce the expected outcomes if patients do not take drugs according to the prescribed method. The World Health Organization has identified factors that drive patient non-adherence to drug regimens: social, economic and behavioral factors; disease or condition-related factors; health system-related factors; and the patient’s experience with the drug.

These external factors contribute to the already complex task of formulating safe and effective drugs that also facilitate a patient’s ability and desire to take medications as prescribed. Formulation methods, new dosage forms, excipients, and technologies can enable drug developers to design drugs that encourage adherence to drug regimens by different patient groups.

In this session, formulation experts will discuss roadblocks to patient adherence, and technologies and processes that can be employed to mitigate these problems.